Frank Forbush
Internal Medicine · Johnson City, TNNPI 1538164660
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $13.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$272
- Novo Nordisk$200
- Astellas Pharma US Inc$143
- AbbVie$120
- Pfizer$105
- Esperion Therapeutics, Inc.$86
- plus $529 from 13 others
What the payments were for
- Food & beverage$1,455100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $272 |
| Novo Nordisk | 22 | $200 |
| Astellas Pharma US Inc | 9 | $143 |
| AbbVie | 8 | $120 |
| Pfizer | 8 | $105 |
| Esperion Therapeutics, Inc. | 5 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $69 |
| GSK | 4 | $69 |
| AstraZeneca | 5 | $63 |
| Bayer | 4 | $61 |
| Johnson & Johnson | 5 | $61 |
| Amgen | 3 | $49 |
| Novartis | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Abbott | 1 | $24 |
| Philips North America LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $13 |
How this compares
$1,455 in reported general payments places this provider in the 70th percentile of 2,216 internal medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 36 | $908 |
| Rosuvastatin Calcium | 66 | $907 |
| Atorvastatin Calcium | 38 | $437 |
| Potassium Chloride | 15 | $410 |
| Losartan Potassium | 49 | $397 |
| Olmesartan Medoxomil | 17 | $372 |
| Amlodipine Besylate | 49 | $323 |
| Tamsulosin Hcl | 26 | $307 |
| Metoprolol Succinate | 17 | $288 |
| Pantoprazole Sodium | 22 | $260 |
| Levothyroxine Sodium | 25 | $253 |
| Metformin Hcl | 24 | $176 |
| Pravastatin Sodium | 11 | $165 |
| Lisinopril | 16 | $138 |
| Sertraline Hcl | 11 | $125 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Johnson City
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
- Maighan SeagroveChattanooga$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.